Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADHD@Home vs Methylphenidate in ADHD
NCT02778360Phase 2Unknown
- Sponsor
- Mensia Technologies
- Start
- Aug 2016
- Primary completion
- Sep 2017
- Countries
- 5
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Mensia Technologies. Primary endpoint: ADHD Rating Scale IV Total Score at Day 90. Status: unknown.
Beyond the preview
Go deeper on NCT02778360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02778360.